These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 29773776)
21. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch". Gamage D; Ginige S; Palihawadana P WHO South East Asia J Public Health; 2018 Sep; 7(2):79-83. PubMed ID: 30136665 [TBL] [Abstract][Full Text] [Related]
22. Anti-polio vaccinations in the third millennia. Icardi G; Tassinari F Ann Ig; 2018; 30(4 Supple 1):11-15. PubMed ID: 30062374 [TBL] [Abstract][Full Text] [Related]
23. Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Más Lago P; Cáceres VM; Galindo MA; Gary HE; Valcarcel M; Barrios J; Sarmiento L; Avalos I; Bravo JA; Palomera R; Bello M; Sutter RW; Pallansch MA; de Quadros CA Int J Epidemiol; 2001 Oct; 30(5):1029-34. PubMed ID: 11689516 [TBL] [Abstract][Full Text] [Related]
24. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States. Sutter RW; Prevots DR; Cochi SL Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505 [TBL] [Abstract][Full Text] [Related]
25. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016. Immunization Systems Management Group of the Global Polio Eradication Initiative MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591 [TBL] [Abstract][Full Text] [Related]
26. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
27. [Worldwide eradication of poliomyelitis]. Rasch G; Schreier E; Kiehl W; Kurth R Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120 [TBL] [Abstract][Full Text] [Related]
28. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Pliaka V; Kyriakopoulou Z; Markoulatos P Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246 [TBL] [Abstract][Full Text] [Related]
29. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis. Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521 [TBL] [Abstract][Full Text] [Related]
31. Safe landing for global polio eradication: a perspective. Arita I; Francis DP Vaccine; 2011 Nov; 29(48):8827-34. PubMed ID: 21959326 [TBL] [Abstract][Full Text] [Related]
32. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016. Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D; MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675 [TBL] [Abstract][Full Text] [Related]
33. [Universal use of inactivated poliovirus vaccine--the needs and challenges]. Shimizu H; Takeda N Nihon Rinsho; 2008 Oct; 66(10):1950-5. PubMed ID: 18939495 [TBL] [Abstract][Full Text] [Related]
34. Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study. Taniuchi M; Famulare M; Zaman K; Uddin MJ; Upfill-Brown AM; Ahmed T; Saha P; Haque R; Bandyopadhyay AS; Modlin JF; Platts-Mills JA; Houpt ER; Yunus M; Petri WA Lancet Infect Dis; 2017 Oct; 17(10):1069-1079. PubMed ID: 28693854 [TBL] [Abstract][Full Text] [Related]
35. Progress towards the global eradication of poliomyelitis. Hull HF; Ward NA World Health Stat Q; 1992; 45(2-3):280-4. PubMed ID: 1462662 [TBL] [Abstract][Full Text] [Related]
36. Polio endgame: Lessons for the global rotavirus vaccination program. Jiang B; Patel M; Glass RI Vaccine; 2019 May; 37(23):3040-3049. PubMed ID: 31027927 [TBL] [Abstract][Full Text] [Related]
37. World Health Organization Guidelines for Containment of Poliovirus Following Type-Specific Polio Eradication - Worldwide, 2015. Previsani N; Tangermann RH; Tallis G; Jafari HS MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(33):913-7. PubMed ID: 26313474 [TBL] [Abstract][Full Text] [Related]
38. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708 [TBL] [Abstract][Full Text] [Related]
39. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy. Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534 [TBL] [Abstract][Full Text] [Related]
40. [Poliomyelitis eradication is a visible unsolved problem in the coming years]. Seĭbil' VB; Malyshkina LP Vopr Virusol; 2011; 56(1):41-4. PubMed ID: 21427955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]